https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2ludGVyY2VwdHMtbmFzaC1kcmVhbXMtY3Jhc2gtYWZ0ZXItZmRhLWV4cGVydC1wYW5lbC12b3Rlcy1hZ2FpbnN0LW9jYWxpdmFzLWJlbmVmaXQtcmlza9IBAA?oc=5
Intercept's NASH dreams may be dashed after FDA panel votes against Ocaliva's approval bid - FiercePharma